159 related articles for article (PubMed ID: 35763110)
61. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
62. Knockdown of RNA-binding protein IMP3 suppresses oral squamous cell carcinoma proliferation by destabilizing E2F5 transcript.
Wang Z; Zhang H; Li F; Huang C
Aging (Albany NY); 2024 Jan; 16(2):1897-1910. PubMed ID: 38271139
[TBL] [Abstract][Full Text] [Related]
63. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
Liu H; Zhang H; Fan H; Tang S; Weng J
Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
[TBL] [Abstract][Full Text] [Related]
64. Methylated RNA Immunoprecipitation Sequencing Reveals the m
Wang X; Wu J; Zhang L; Zhao W; Deng J
J Immunol Res; 2022; 2022():7277583. PubMed ID: 35874897
[TBL] [Abstract][Full Text] [Related]
65. Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.
Hsieh YP; Chen KC; Chen MY; Huang LY; Su AY; Chiang WF; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562900
[TBL] [Abstract][Full Text] [Related]
66. MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
Jiang L; Lv L; Liu X; Jiang X; Yin Q; Hao Y; Xiao L
Cancer Biomark; 2019; 24(3):325-334. PubMed ID: 30883339
[TBL] [Abstract][Full Text] [Related]
67. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
Luo R; Xie L; Lin Y; Shao J; Lin Z
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481
[TBL] [Abstract][Full Text] [Related]
68. Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis.
Liu D; Jian X; Xu P; Zhu R; Wang Y
BMC Cancer; 2020 Feb; 20(1):107. PubMed ID: 32041570
[TBL] [Abstract][Full Text] [Related]
69. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
Wu J; Li Y; Liu J; Xu Y
J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
[TBL] [Abstract][Full Text] [Related]
70. LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis.
Liu X; Ma X; Li H; Wang Y; Mao M; Liang C; Hu Y
Bioengineered; 2022 Jan; 13(1):1162-1173. PubMed ID: 35258410
[TBL] [Abstract][Full Text] [Related]
71. Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop.
Zhao W; Cui Y; Liu L; Qi X; Liu J; Ma S; Hu X; Zhang Z; Wang Y; Li H; Wang Z; Liu Z; Wu J
Cell Death Differ; 2020 Mar; 27(3):919-933. PubMed ID: 31570856
[TBL] [Abstract][Full Text] [Related]
72. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
[TBL] [Abstract][Full Text] [Related]
73. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
74. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
75. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
[TBL] [Abstract][Full Text] [Related]
76. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
Li X; Ren H
Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
[TBL] [Abstract][Full Text] [Related]
77. LINC01123 is associated with prognosis of oral squamous cell carcinoma and involved in tumor progression by sponging miR-34a-5p.
Qin H; Wang C; Hua Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):50-59. PubMed ID: 34511356
[TBL] [Abstract][Full Text] [Related]
78. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
79. Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis.
Zhang J; Peng Y; Jiang S; Li J
J Clin Lab Anal; 2022 Mar; 36(3):e24245. PubMed ID: 35060189
[TBL] [Abstract][Full Text] [Related]
80. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
Cui SH; Hu XD; Yan Y
J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
